Logo

Quidel

QuidelOrtho Revenues up 8 Percent in Q2

On a conference call, its CEO said the future menu for the Savanna instrument will include respiratory panels, panels for other STDs, a panel for GI infections, and other tests.

QuidelOrtho Partners With BYG4lab for Lab Informatics

The partnership is intended to expand and strengthen QuidelOrtho's informatics offering across its diagnostics portfolio.

QuidelOrtho Preliminary Q4 Earnings Beat Estimates

The firm expects its Q4 non-COVID core revenues to increase approximately 18 percent and full-year core revenues to increase approximately 11 percent.

QuidelOrtho Continues to See Supply Chain Impacts; Combined Q3 Revenues up 54 Percent
Premium

The firm also said it will shift its near-term regulatory and commercial strategy for its Savanna molecular diagnostic instrument.

GenomeWeb Top 40 up 3 Percent in October After Two Months of Losses

The Dow Jones Industrial Average was up 14 percent, while the Nasdaq was up 4 percent, and the Nasdaq Biotech Index was up 9 percent.

Oct 12, 2022

QuidelOrtho Reports Preliminary Q3 Revenues

Aug 18, 2022

QuidelOrtho Board Authorizes $300M Share Repurchase

Aug 5, 2022

QuidelOrtho Q2 Revenues Rise 34 Percent

Jul 20, 2022

UBS Initiates Coverage on QuidelOrtho, Waters, PerkinElmer, Hologic, Agilent Technologies

May 27, 2022

In Brief This Week: SQI Diagnostics, T2 Biosystems, Enhanc3D, QuidelOrtho, More

May 4, 2022

Quidel Q1 Revenues More Than Double on COVID-19 Immunoassay Sales

Apr 8, 2022

Quidel Expects up to $1B in Q1 Revenues

Feb 17, 2022

Quidel Q4 Revenues Drop 21 Percent, Beat Estimates

Jan 13, 2022

JPM Healthcare Conference Day 3: Quantum-Si, Olink, Exact Sciences, Bio-Techne, Opko Health, More

Jan 6, 2022

Quidel Preliminary Q4 Revenues Drop 21 Percent, Beat Estimates

Dec 1, 2021

GenomeWeb Index Falls 6 Percent in November as Emergence of Omicron Spooks Markets

Nov 4, 2021

Quidel Q3 Revenues Up 7 Percent, Beat Analysts' Estimate

Oct 8, 2021

Quidel Preliminary Q3 Revenues Rise, Easily Beat Analysts' Estimate

Oct 1, 2021

GenomeWeb Index Takes 7 Percent Tumble in September

Aug 5, 2021

Quidel Q2 Revenues Dip 12 Percent; Misses on Revenues and EPS Estimates

Jul 26, 2021

Quidel, Beckman Coulter Settle Legal Dispute Over Cardiac Immunoassay Business

Jul 19, 2021

OraSure Stock Ticks Up on Rumor of Declined Quidel Acquisition Offer

Jul 12, 2021

Quidel Nabs CE Mark for Savanna Analyzer, Respiratory Panel

Jul 7, 2021

Quidel Recalls Lyra SARS-CoV-2 Test Due to Potential False Negative Results

Jun 1, 2021

GenomeWeb Index Down in May as NanoString Technologies Falls 30 Percent From April

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.